dr. Isabelle Desombere
Show
Sort by
-
Humoral and cellular immune responses to subepidermal E1-based therapeutic vaccination in healthy volunteers and patients with past or ongoing HCV infections
-
Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B.
-
Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/ASO4, a hepatitis B vaccine with a novel adjuvant.
-
Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
-
The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population.
-
Prevention of hepatitis B infections: Vaccination and its limitations
-
A candidate therapeutic vaccine for chronic hepatitis C infection based on envelope 1 protein: Tolerability and immunogenicity in healthy adult volunteers
-
In vivo inhibition of anti-HBcIgG production by HBcAg-specific CD4+Th1-type T cell clones in a hu-PBL-NOD/SCID mice model
-
Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults
-
Hepatitis B virus core antigen binds and activates naive human B cells in vivo: Studies with a human PBL-NOD/SCID mouse model.